Allstate Corporation’s Alexion Pharmaceuticals ALXN Stock Holding History

Allstate Corporation’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,319	Closed	-$426K	–	730
2021 Q2	$426K	Hold	2,319	–	–	0.01%	565
2021 Q1	$355K	Buy	2,319 +422	+22%	+$65.3K	0.01%	629
2020 Q4	$296K	Buy	1,897 +87	+5%	+$11.2K	0.01%	624
2020 Q3	$207K	Sell	1,810 -3,801	-68%	-$410K	0.01%	647
2020 Q2	$630K	Buy	+5,611	New	+$596K	0.02%	367
2019 Q4	–	Sell	-3,662	Closed	-$359K	–	655
2019 Q3	$359K	Sell	3,662 -5,640	-61%	-$636K	0.01%	454
2019 Q2	$1.22M	Buy	9,302 +377	+4%	+$48.6K	0.02%	371
2019 Q1	$1.21M	Buy	8,925 +6,249	+234%	+$777K	0.03%	285
2018 Q4	$261K	Buy	+2,676	New	+$316K	0.01%	366
2017 Q2	–	Sell	-14,957	Closed	-$1.81M	–	320
2017 Q1	$1.81M	Sell	14,957 -26,213	-64%	-$3.38M	0.11%	129
2016 Q4	$5.04M	Buy	+41,170	New	+$5.04M	0.3%	104

Other funds holding ALXN

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return